{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:40:09Z","timestamp":1756291209552,"version":"3.44.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0304C"],"award-info":[{"award-number":["031L0304C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["465194077"],"award-info":[{"award-number":["465194077"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.dmd.2025.100111","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:47:43Z","timestamp":1750168063000},"page":"100111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CYP1A2 expression and activity in a large panel of human nonneoplastic surgical liver samples: Influence of genetics, lifestyle, and other factors"],"prefix":"10.1016","volume":"53","author":[{"given":"Urs Dieter","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Ga\u00dfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-9391","authenticated-orcid":false,"given":"Hans-Michael","family":"Tautenhahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utz","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-7310","authenticated-orcid":false,"given":"Amelie","family":"Lupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.dmd.2025.100111_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/14622416.9.5.625","article-title":"Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms","volume":"9","author":"Gunes","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/18755453MTEyCOTgcx","article-title":"Metabolism and mechanism of human cytochrome P450 enzyme 1A2","volume":"22","author":"Guo","year":"2021","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.dmd.2025.100111_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147171","article-title":"Genic-intergenic polymorphisms of CYP1A genes and their clinical impact","volume":"857","author":"Kukal","year":"2023","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12272-021-01306-w","article-title":"Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes","volume":"44","author":"Kwon","year":"2021","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00204-020-02971-4","article-title":"Human family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update","volume":"95","author":"Rendic","year":"2021","journal-title":"Arch Toxicol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/mol.64.3.659","article-title":"Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1","volume":"64","author":"Aklillu","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00228-003-0623-1","article-title":"Determination of \u22123858G\u2192A and \u2212164C\u2192A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the \u22123858G\u2192A mutation between Caucasians and Asians","volume":"59","author":"Todesco","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100111_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-007-0288-2","article-title":"Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans","volume":"63","author":"Ghotbi","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib10","first-page":"511","article-title":"Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry","volume":"92","author":"Perera","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","article-title":"Functional significance of a C\u2192A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine","volume":"47","author":"Sachse","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100111_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00228-010-0823-4","article-title":"Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism","volume":"66","author":"Djordjevic","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45752-6","article-title":"CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients","volume":"13","author":"Fekete","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100111_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fphar.2010.00129","article-title":"Pathway-targeted pharmacogenomics of CYP1A2 in human liver","volume":"1","author":"Klein","year":"2010","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.dmd.2025.100111_bib16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/clpt.2011.70","article-title":"Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility","volume":"90","author":"Dobrinas","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.111.189597","article-title":"Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression","volume":"341","author":"Temesv\u00e1ri","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/dmd.113.055632","article-title":"Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100111_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2016.06.015","article-title":"Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes","volume":"92","author":"Gao","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"31","key":"10.1016\/j.dmd.2025.100111_bib21","doi-asserted-by":"crossref","first-page":"50612","DOI":"10.18632\/oncotarget.9437","article-title":"Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.dmd.2025.100111_bib22","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1021\/acs.molpharmaceut.8b00787","article-title":"Intraindividual variation and correlation of cytochrome P450 activities in human liver microsomes","volume":"15","author":"Fang","year":"2018","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a022352","article-title":"Genetic polymorphism in the 5\u2019-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans","volume":"125","author":"Nakajima","year":"1999","journal-title":"J Biochem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.103.055798","article-title":"Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes","volume":"308","author":"Murayama","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100111_bib25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.csbj.2021.01.022","article-title":"QuPath: the global impact of an open source digital pathology system","volume":"19","author":"Humphries","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"9","key":"10.1016\/j.dmd.2025.100111_bib26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12876-020-1161-3","article-title":"Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0005-8165(73)80016-2","article-title":"Polarization microscopic studies of connective tissue stained with picro-sirius red FBA","volume":"150","author":"Puchtler","year":"1973","journal-title":"Beitr Path"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem J"},{"issue":"10","key":"10.1016\/j.dmd.2025.100111_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1369\/0022155414545787","article-title":"Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues","volume":"62","author":"Lattouf","year":"2014","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib31","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib32","first-page":"149","article-title":"The influence of age on the protein concentration in serum, liver and kidney of rats determined by various methods","volume":"16","author":"Klinger","year":"1974","journal-title":"Z Versuchstierkd"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0003-2697(78)90245-2","article-title":"A simple and sensitive assay of 7-ethoxycoumarin deethylation","volume":"85","author":"Aitio","year":"1978","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0003-2697(80)90505-9","article-title":"A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions","volume":"107","author":"Pohl","year":"1980","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1432-1033.1992.tb16650.x","article-title":"Zonation of cytochrome P450 isozyme expression and induction in rat liver","volume":"204","author":"B\u00fchler","year":"1992","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0163-7258(92)90055-5","article-title":"Metabolic zonation of the liver: regulation and implications for liver function","volume":"53","author":"Gebhardt","year":"1992","journal-title":"Pharmacol Ther"},{"issue":"3 suppl","key":"10.1016\/j.dmd.2025.100111_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jn\/122.suppl_3.843","article-title":"Metabolic heterogeneity of hepatocytes across the liver acinus","volume":"122","author":"Katz","year":"1992","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01454004","article-title":"Zonation of metabolism and gene expression in liver","volume":"103","author":"Jungermann","year":"1995","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-3623(96)00183-8","article-title":"Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver","volume":"28","author":"Lindros","year":"1997","journal-title":"Gen Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj3290017","article-title":"Zonation of hepatic cytochrome P-450 expression and regulation","volume":"329","author":"Oinonen","year":"1998","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2020.05.202","article-title":"Visualization and isolation of zone-specific murine hepatocytes that maintain distinct cytochrome P450 oxidase expression in primary culture","volume":"528","author":"Kasahara","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmd.2025.100111_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.732929","article-title":"Liver zonation\u2014revisiting old questions with new technologies","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib43","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhep.2020.09.003","article-title":"Liver zonation","volume":"74","author":"Manco","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0041-1742279","article-title":"The role of liver zonation in physiology, regeneration, and disease","volume":"42","author":"Panday","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dmd.2025.100111_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1404938","article-title":"Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4","volume":"15","author":"Albadry","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1249\/MSS.0000000000003313","article-title":"Caffeine, CYP1A2 genotype, and exercise performance: a systematic review and meta-analysis","volume":"56","author":"Barreto","year":"2024","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/jpet.116.233635","article-title":"Physiological content and intrinsic activities of 10 cytochrome P450 isoforms in human normal liver microsomes","volume":"358","author":"Zhang","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-3565(25)23168-8","article-title":"Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples","volume":"256","author":"Guengerich","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.dmd.2025.100111_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002280050394","article-title":"A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers","volume":"53","author":"Schrenk","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib50","first-page":"131","article-title":"Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test","volume":"9","author":"Tantcheva-Po\u00f3r","year":"1999","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.dmd.2025.100111_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2125.2000.00128.x","article-title":"Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population","volume":"49","author":"Ou-Yang","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100111_bib52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","article-title":"The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis","volume":"18","author":"Koonrungsesomboon","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.dmd.2025.100111_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200107000-00006","article-title":"Plasma caffeine metabolite ratio (17X\/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2","volume":"11","author":"Han","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.toxlet.2004.12.005","article-title":"CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico","volume":"156","author":"Castorena-Torres","year":"2005","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clpt.2005.05.012","article-title":"The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population","volume":"78","author":"Chen","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2025.100111_bib56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/pgs.09.22","article-title":"Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population","volume":"10","author":"Gunes","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.dmd.2025.100111_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00228-005-0057-z","article-title":"Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy","volume":"62","author":"Takata","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5415\/apallergy.2013.3.4.231","article-title":"CYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics","volume":"3","author":"Yim","year":"2013","journal-title":"Asia Pac Allergy"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100111_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrgentox.2005.08.008","article-title":"Influence of the genetic polymorphism in the 5\u2019-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers","volume":"587","author":"Pavanello","year":"2005","journal-title":"Mutat Res"},{"issue":"5","key":"10.1016\/j.dmd.2025.100111_bib60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2125.2002.01673.x","article-title":"The effect of the CYP1A2 \u22171F mutation on CYP1A2 inducibility in pregnant women","volume":"54","author":"Nordmark","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100111_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0027-5107(97)00036-5","article-title":"Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2","volume":"376","author":"MacLeod","year":"1997","journal-title":"Mutat Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100111_bib62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2125.1996.35418.x","article-title":"CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine","volume":"41","author":"Carrillo","year":"1996","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100111_bib63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0006-2952(01)00716-X","article-title":"Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples","volume":"62","author":"Baker","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","article-title":"The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes","volume":"199","author":"Parkinson","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00498254.2020.1867929","article-title":"Expression of cytochrome P450 isozyme transcripts and activities in human livers","volume":"51","author":"Liu","year":"2021","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.dmd.2025.100111_bib66","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/clpt.1992.203","article-title":"Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities","volume":"52","author":"Relling","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00544361","article-title":"Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives","volume":"28","author":"Abernethy","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib68","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clpt.2005.06.009","article-title":"Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2","volume":"78","author":"Granfors","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100111_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cobeha.2018.08.004","article-title":"Gender-related differences in addiction: a review of human studies","volume":"23","author":"Zakiniaeiz","year":"2018","journal-title":"Curr Opin Behav Sci"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/00912700022008955","article-title":"Higher incidence of elevated body temperature or increased C-reactive protein level in asthmatic children showing transient reduction of theophylline metabolism","volume":"40","author":"Yamaguchi","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2025.100111_bib71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s002280100375","article-title":"Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia","volume":"57","author":"Raaska","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/JCP.0b013e3181acd20b","article-title":"Toxic clozapine serum levels during inflammatory reactions","volume":"29","author":"Pfuhlmann","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100111_bib73","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00213-015-3976-0","article-title":"Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels","volume":"233","author":"Hefner","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.dmd.2025.100111_bib74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000506355","article-title":"Around 3% of 1,300 levels were elevated during infections in a retrospective review of 131 Beijing hospital in-patients with more than 24,000 days of clozapine treatment","volume":"89","author":"Ruan","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"7","key":"10.1016\/j.dmd.2025.100111_bib75","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/10600280211047864","article-title":"Inflammation suppresses patients\u2019 ability to metabolize cytochrome P450 substrate drugs","volume":"56","author":"White","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.dmd.2025.100111_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clpt.2006.05.006","article-title":"Liver disease selectively modulates cytochrome P450-mediated metabolism","volume":"80","author":"Frye","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dmd.2025.100111_bib77","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/pharmaceutics13091334","article-title":"Gene expression and protein abundance of hepatic drug metabolizing enzymes in liver pathology","volume":"13","author":"Drozdzik","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:12:43Z","timestamp":1756289563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0090955625091202"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100111","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP1A2 expression and activity in a large panel of human nonneoplastic surgical liver samples: Influence of genetics, lifestyle, and other factors","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100111"}}